BC006 for idiopathic pulmonary fibrosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Mar 2026: Trial registered, NCT07447102
  2. 27 Apr 2026: Trial started, NCT07447102

The trials

NCT07447102: Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis

State
Under way
Phase
Phase 2
People
96 planned
Started
27 Apr 2026
Primary completion
1 Apr 2029
Arms
BC006
Results
None posted
  1. 3 Mar 2026: Trial registered
  2. 27 Apr 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.